IP News

New developments in intellectual property right assorted by our patent attorneys and attorneys at law.


Clinical trials and personalised medicines – life sciences patentability issues in Europe


By Wolfgang Weiss and Christian Heubeck, Weickmann & Weickmann. This article first appeared in IAM Yearbook 2020, a supplement to IAM, published by Globe Business Media Group - IP Division.

Guideline for Validly Claiming Priorities


Losing priority may cause the loss of a protective right. In the following, we provide guidelines to prevent priority being lost for mere formal reasons.

Preliminary Injunction on the Basis of a German Utility Model


A request for Preliminary Injunction based on a utility is the fastest way to take action against a potential infringer. Many courts in Germany dismiss such request on the basis of an unexamined protective right. In any case, the...

Some remarks on the new Rules of Procedure of the Boards of Appeal


The Boards of Appeal of the European Patent Office, i.e. the judicial panel of the second instance of the EPO, examine appeals from the decisions of the Receiving Section, the Examining and Opposition Divisions of the European...

The end of the certification requirement for German translations?


According to current German Patent Regulation (§14 PatV), when filing a German translation of a patent application that has been filed in a foreign language, a certificate has to be filed together with the translation which...

Oral proceedings before the Boards of Appeal remain in Haar


On July 16, 2019, oral proceedings before the Enlarged Boards of Appeal regarding referral G 2/19 took place in the main building of the European Patent Office in Munich. Therein, the Enlarged Boards of Appeal dealt with the...

Risks to Validity of German Utility Models


A Short Introduction to German Utility Models versus Patents – Part 4

Displaying results 1 to 7 out of 47
<< First < Previous 1-7 8-14 15-21 22-28 29-35 36-42 43-47 Next > Last >>